- Home
- VRCA vs FONR Comparison
VRCA vs FONR Comparison
Compare VRCA & FONR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VRCA
- FONR
- Stock Information
- Founded
- VRCA 2013
- FONR 1978
- Country
- VRCA United States
- FONR United States
- Employees
- VRCA N/A
- FONR N/A
- Industry
- VRCA Biotechnology: Pharmaceutical Preparations
- FONR Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- VRCA Health Care
- FONR Health Care
- Exchange
- VRCA Nasdaq
- FONR Nasdaq
- Market Cap
- VRCA 80.7M
- FONR 77.1M
- IPO Year
- VRCA 2018
- FONR 1987
- Fundamental
- Price
- VRCA $5.99
- FONR $15.77
- Analyst Decision
- VRCA Hold
- FONR
- Analyst Count
- VRCA 5
- FONR 0
- Target Price
- VRCA $6.00
- FONR N/A
- AVG Volume (30 Days)
- VRCA 57.3K
- FONR 32.6K
- Earning Date
- VRCA 08-13-2025
- FONR 05-15-2025
- Dividend Yield
- VRCA N/A
- FONR N/A
- EPS Growth
- VRCA N/A
- FONR N/A
- EPS
- VRCA N/A
- FONR 1.28
- Revenue
- VRCA $7,179,000.00
- FONR $103,018,089.00
- Revenue This Year
- VRCA $165.25
- FONR N/A
- Revenue Next Year
- VRCA $80.06
- FONR N/A
- P/E Ratio
- VRCA N/A
- FONR $12.47
- Revenue Growth
- VRCA N/A
- FONR 0.29
- 52 Week Low
- VRCA $3.82
- FONR $12.00
- 52 Week High
- VRCA $71.40
- FONR $18.64
- Technical
- Relative Strength Index (RSI)
- VRCA 38.77
- FONR 54.41
- Support Level
- VRCA $5.86
- FONR $15.85
- Resistance Level
- VRCA $7.13
- FONR $16.22
- Average True Range (ATR)
- VRCA 0.88
- FONR 0.30
- MACD
- VRCA -0.28
- FONR -0.08
- Stochastic Oscillator
- VRCA 6.01
- FONR 2.60
About VRCA Verrica Pharmaceuticals Inc.
Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its product candidate, VP-102, is developed for the treatment of molluscum contagiosum, or molluscum, a contagious and pediatric viral skin disease, and common warts.
About FONR Fonar Corporation
Fonar Corp is a United States-based company which is engaged in the business of designing, manufacturing, selling and servicing magnetic resonance imaging (MRI) scanners, which utilize MRI technology for the detection and diagnosis of human disease, abnormalities, other medical conditions, and injuries. The company operates through two segments namely Manufacturing and servicing of medical equipment; and the Management of diagnostic imaging centers, which generates a vast majority of the revenue.